Maine PBM Law Clears Hurdle; Magistrate Judge Recommends Lifting Injunction
This article was originally published in The Pink Sheet Daily
Executive Summary
If approved, the decision would allow implementation of law requiring PBM transparency of rebates and other financial arrangements. Magistrate judge says law would not automatically result in regulatory "taking" of trade secrets. PCMA will seek full review by the district court.
You may also be interested in...
PCMA Will Appeal Court Decision Upholding Maine’s PBM Transparency Law
Bangor, Maine federal court adopts magistrate judge’s recommendation that preliminary injunction against Maine law be overturned. PCMA is seeking to block the law based on federal preemption under ERISA and a violation of the Takings Clause of the U.S. Constitution.
PCMA Will Appeal Court Decision Upholding Maine’s PBM Transparency Law
Bangor, Maine federal court adopts magistrate judge’s recommendation that preliminary injunction against Maine law be overturned. PCMA is seeking to block the law based on federal preemption under ERISA and a violation of the Takings Clause of the U.S. Constitution.
Maine Rx Not Required To Seek HHS Approval At This Time, Court Says
PhRMA's request that the state be required to seek HHS clearance of its drug discount program is denied. Judge says the unimplemented program is not "ripe" for review and PhRMA may reassert its challenge if Maine attempts to use the prior authorization provisions in its program.